BIOTECHNOLOGY ULTRASECTOR Potential Upside
| BIPIX Fund | | | USD 78.93 3.29 4.35% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is BIOTECHNOLOGY ULTRASECTOR's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
At 4.35, BIOTECHNOLOGY ULTRASECTOR exhibits modest estimated upside from current levels in Potential Upside. BIOTECHNOLOGY ULTRASECTOR trades near but slightly below the model-derived fair value estimate.
Potential Upside | = | 1PM2PM |
| = | 4.35 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Relative to peers, BIOTECHNOLOGY ULTRASECTOR's Potential Upside is above the group average of 2.03. Peer readings range from 0.8881 (Columbia Adaptive Risk) to 4.35 (Biotechnology Ultrasector Profund), reflecting wide dispersion across the sector. BIOTECHNOLOGY ULTRASECTOR shows greater estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Biotechnology Ultrasector and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
BIOTECHNOLOGY ULTRASECTOR's Maximum Drawdown of
14.31 runs about
3.29 times its Potential Upside of
4.35 . This indicates Maximum Drawdown is significantly higher than Potential Upside for BIOTECHNOLOGY ULTRASECTOR.
Methodology, Assumptions & Data Sources
The current Potential Upside for BIOTECHNOLOGY ULTRASECTOR is 4.35. The Potential Upside for BIOTECHNOLOGY ULTRASECTOR is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. BIOTECHNOLOGY ULTRASECTOR operates in the trading--leveraged equity sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.
Other Technical Indicators